Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGOBSERVATIONAL

Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

The goal of this observational study is to collect information on the use of the HistoSonics Edison System for the treatment of liver tumors. The main aim is to understand how different patient characteristics and procedural characteristics may affect histotripsy success at 36 hours post-histotripsy procedure. Sub-studies to the BOOMBOX: Master Study will investigate specific populations and/or clinical questions with more stringent enrollment criteria, standardized testing criteria, and/or follow-up schedule. Any participant enrolled in the BOOMBOX: Master Study that also qualifies for a sub-study may enroll in the sub-study in parallel; sub-studies will be described in separate sub-study protocols. The BOOMBOX: Master Study will collect information about participants before, during, and after the histotripsy treatment procedure. All participants will be followed per standard clinical follow-up based on each site's clinical practice for up to 5 years after the initial histotripsy procedure or until completion of their follow-up in a sub-study, whichever is longer.

Who May Be Eligible (Plain English)

Who May Qualify: 1. Subject is ≥22 years of age 2. Subject has signed the Ethics Committee (EC), or Institutional Review Board (IRB) approved study willing to sign a consent form Form (ICF) prior to any study related tests/procedures and is willing to comply with study procedures and required follow-up assessments 3. Subject's liver tumor(s) can be partially or completely treated with histotripsy Who Should NOT Join This Trial: 1. Subject is pregnant or planning to become pregnant or nursing (lactating) during the study period 2. Subject is enrolled in an interventional HistoSonics-sponsored trial 3. Subject has a concurrent condition that, in the investigator's opinion, could jeopardize the safety of the subject or compliance with the protocol Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: 1. Subject is ≥22 years of age 2. Subject has signed the Ethics Committee (EC), or Institutional Review Board (IRB) approved study Informed Consent Form (ICF) prior to any study related tests/procedures and is willing to comply with study procedures and required follow-up assessments 3. Subject's liver tumor(s) can be partially or completely treated with histotripsy Exclusion Criteria: 1. Subject is pregnant or planning to become pregnant or nursing (lactating) during the study period 2. Subject is enrolled in an interventional HistoSonics-sponsored trial 3. Subject has a concurrent condition that, in the investigator's opinion, could jeopardize the safety of the subject or compliance with the protocol

Treatments Being Tested

DEVICE

HistoSonics Edison System

Histotripsy with the HistoSonics Edison System for the full or partial destruction of liver tumors

Locations (20)

Providence St. Jude
Fullerton, California, United States
Mission Hospital
Mission Viejo, California, United States
Hoag
Newport Beach, California, United States
Sutter Bay Hospitals
San Francisco, California, United States
Providence Saint John's Health Center
Santa Monica, California, United States
AdventHealth Altamonte Springs
Altamonte Springs, Florida, United States
AdventHealth Celebration
Celebration, Florida, United States
Lee Health Cancer Institute
Fort Myers, Florida, United States
Baptist Health Miami Cardiac & Vascular Institute
Miami, Florida, United States
Northeast Georgia Medical Center
Gainesville, Georgia, United States
RUSH University Medical Center
Chicago, Illinois, United States
University of Chicago
Chicago, Illinois, United States
Willis Knighton Health
Shreveport, Louisiana, United States
Henry Ford Health
Detroit, Michigan, United States
University of Michigan Health - West
Wyoming, Michigan, United States
Renown Regional Medical Center
Reno, Nevada, United States
NYU Langone Health
New York, New York, United States
Columbia University Irving Medical Center
New York, New York, United States
Weill Cornell Medicine
New York, New York, United States
University of Rochester Medical Center
Rochester, New York, United States